• Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Oncology
  • AI
  • Topics
    • Back to parent navigation item
    • Topics
    • Technology
    • Resources
    • Diseases
    • Drugs and therapies
    • Research and development
    • Tools and techniques
    • Business
  • Webinars
  • Reports
  • Home
  • News
  • Oncology
  • AI
  • Topics
      • Technology
      • Resources
      • Diseases
      • Drugs and therapies
      • Research and development
      • Tools and techniques
      • Business
    • Conference Hall
      AACR 2026 part two: integrating AI, spatial biology and next-gen therapeutics
    • AACR 2
      AACR 2026 part one: AI design, precision biology and the next wave of oncology innovation
    • 16_Still01_Bo and Lexi looking at computer_cleaned
      When scale meets insight: reinventing SPR for the future of drug discovery
  • Webinars
  • Reports
  • More navigation items

Premium members qualification

  • No comments

Topics

  • Neurological disorders
  • No comments

Related articles

  • shutterstock_2779261629
    News

    KCL-286 targets multiple Alzheimer’s pathways in preclinical study

    2026-07-09T09:00:00Z

    By Drug Target Review

  • shutterstock_2718496253
    News

    15-PGDH enzyme inhibition protects brain cells in Parkinson’s disease models

    2026-07-07T12:00:00Z

    By Drug Target Review

  • shutterstock_2667999575
    News

    XL20 drug candidate shields motor neurons from ALS-linked TDP-43 damage

    2026-07-06T09:00:00Z

    By Drug Target Review

  • shutterstock_2678738361
    News

    ATRX mutations reprogram chromatin to drive glioma progression

    2026-07-02T12:00:00Z

    By Drug Target Review

  • shutterstock_2788060121
    News

    Cerebral organoids identify Ebola virus persistence in neural tissue

    2026-06-23T09:12:00Z

    By Drug Target Review

  • shutterstock_2396604667
    News

    Thalidomide shows potential for treating rare brain vascular malformations

    2026-06-22T13:04:00Z

    By Drug Target Review

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register

Partner content

  • Computer,Screen,With,Molecular,Modelling,Software,Simulating,Proteins,,Designing,New
    Webinar

    The truth about AI in drug discovery: what the experts really think

    2026-03-11T14:00:00

    Sponsored by Merck

  • shutterstock_2771790713
    Article

    Women in STEM: resilience and leadership in rare disease research

    2026-05-19T09:46:00

    Contributor Dr Nitza Thomasson

  • CELLVO~1
    Webinar

    What it takes to automate high-content imaging at scale

    2026-03-25T15:00:00

    Sponsored by Yokogawa

  • Video Template (horizonal black ipad) asset 2
    Whitepaper

    Infographic: Biologics stability in early development

    2023-09-06T16:55:04

    Sponsored by NanoTemper Technologies

  • Embryonic,Stem,Cells,,,Cellular,Therapy,,,3d,Rendering
    Webinar

    The future of carcinogenicity risk assessment: AI-powered, ethical alternatives to traditional testing

    2025-04-02T14:00:00

    Sponsored by Eurofins Discovery

  • Client Asset Template - Whitepapers&Application note (vertical white ipad) copy
    Whitepaper

    Guide: Tips for Single Cell Isolation

    2023-03-14T10:07:00

    Sponsored by Bio-Techne

  • Topics
  • Technology
  • Resources
  • Diseases
  • Drugs and therapies
  • Research and development
  • Tools and techniques
  • Business
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
The trusted voice in drug discovery
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 Drug Target Review

Site powered by Webvision Cloud